technetium-tc-99m-medronate has been researched along with Graft-vs-Host-Disease* in 3 studies
3 other study(ies) available for technetium-tc-99m-medronate and Graft-vs-Host-Disease
Article | Year |
---|---|
Spleen Uptake on Bone Scan After Frequent Platelet and RBC Transfusions.
A 21-year-old man, allogeneic hematopoietic stem cell transplantation recipient, was referred to our nuclear medicine department for a suspicion of knee osteonecrosis. Bone scan with Tc-HMDP did not show abnormal bone uptake but an intense spleen accumulation. F-FDG PET/CT performed on the same day showed no pathological spleen uptake. The patient had secondary hemochromatosis resulting from frequent transfusions in the setting of a chronic graft versus host disease with hemolysis and thrombocytopenia. The last RBC and platelet transfusions were performed 9 and 2 days before the examination, respectively. Secondary hemochromatosis and recent transfusions may explain our findings. Topics: Bone and Bones; Erythrocyte Transfusion; Fluorodeoxyglucose F18; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Platelet Transfusion; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Spleen; Technetium Tc 99m Medronate; Young Adult | 2016 |
Tc-99m MDP bone scintigraphy of myositis as a manifestation of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation.
A 27-year-old man developed polymyositis as a manifestation of chronic graft-versus-host disease (GVHD) after non-myeloablative peripheral blood stem cell transplantation (PBSCT). Bone scintigraphy showed intense, striped, and heterogeneous accumulation of Tc-99m methylene diphosphonate (MDP) in the soft-tissue of his lower limbs, while faint activities were seen in the right upper limb. Tc-99m MDP scintigraphy was very useful for accurate and objective evaluation of the severity of the muscle injury and the extent of polymyositis caused by chronic GVHD. Topics: Adult; Bone and Bones; Extremities; Graft vs Host Disease; Humans; Male; Myositis; Peripheral Blood Stem Cell Transplantation; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate | 2005 |
Two patients with abnormal skeletal muscle uptake of Tc-99m hydroxymethylene diphosphonate following liver transplant: nephrogenic fibrosing dermopathy and graft vs host disease.
Tc-99m hydroxymethylene disphosphonate administered for skeletal scintigraphy may be seen in the extraosseous tissues for various etiologies. This report presents similar abnormal lower extremity skeletal muscle uptake in 2 patients status postorthotopic liver transplant. Although the history and scintigraphic appearance of the 2 were similar, subtle differences in cutaneous lesions and histology led to disparate diagnoses. Topics: Fibrosis; Graft vs Host Disease; Humans; Kidney Diseases; Liver Transplantation; Male; Middle Aged; Muscle, Skeletal; Radionuclide Imaging; Radiopharmaceuticals; Skin Diseases; Technetium Tc 99m Medronate | 2004 |